• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

59.12 -0.46 (-0.77%)
Official Closing Price Updated: 7:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,253,530
Open 58.88
Bid (Size) 59.05 (100)
Ask (Size) 59.50 (6,000)
Prev. Close 59.58
Today's Range 58.74 - 59.79
52wk Range 42.52 - 68.64
Shares Outstanding 2,222,113,553
Dividend Yield 4.26%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? ↗
October 10, 2026
You'll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and Bristol Myers Squibb. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? ↗
October 10, 2026
Bristol Myers Squibb trades at a steeper discount despite higher leverage, while Novo Nordisk commands a premium on exceptional profitability and GLP-1 dominance. 
Via The Motley Fool

Performance

52-Week Range 13.9% below 52-week high
59.12
42.5252W Low 68.6452W High
1 Week 1.7% below 1-week high
58.331W Low 60.151W High

Bristol-Myers Squibb (BMY) traded between $42.52 and $68.64 over the past 52 weeks and last traded at $59.12, 13.9% below its 52-week high. Over the past week it ranged between $58.33 and $60.15.

Past 12 Months
+0.5%
-7.3%
-0.4%
+1.8%
+10.6%
+34.5%
1W +$0.31
1M -$4.63
3M -$0.22
6M +$1.06
YTD +$5.66
1Y +$15.16

BMY was +34.5% over the past year, +1.8% over six months, +10.6% year to date, +0.5% in the last week.

12 Months vs Market
BMY
+34.5%
DIA
+13.5%
SPY
+19.2%
QQQ
+27.4%
IWM
+17.3%

Over the past 12 months BMY returned +34.5% versus DIA (Dow) +13.5%, SPY (S&P 500) +19.2%, QQQ (Nasdaq 100) +27.4% and IWM (Russell 2000) +17.3%.

Volume & Liquidity 0.82× 3-mo avg
Today 9,253,530 3-mo avg 11.3M
1W
12.5M
1M
12.8M
3M
11.3M
6M
11.5M
YTD
12.1M
1Y
12.9M

BMY most recently traded 9,253,530 shares against a 3-month average daily volume of 11.3M.

More News

Read More
News headline image
2 Profitable Stocks to Target This Week and 1 We Find Risky
October 09, 2026
Via StockStory
Bristol-Myers Squibb (NYSE:BMY) Dividend Quality: High Yield, Sustainability Concerns ↗
October 03, 2026
Via Chartmill
News headline image
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗
October 08, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3...
October 08, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
2 High-Yield Stocks to Buy in October (Hint: Bristol Myers Squibb Is One) ↗
October 07, 2026
Via The Motley Fool
Topics Bonds Intellectual Property
Uncover the latest developments among S&P500 stocks in today's session. ↗
October 05, 2026
Via Chartmill
Which S&P500 stocks are moving on Monday? ↗
October 05, 2026
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
October 05, 2026
Via Chartmill
News headline image
3 Value Stocks We Steer Clear Of
October 05, 2026
Via StockStory
News headline image
3 Dirt Cheap Dividend Stocks Worth Buying in October ↗
October 04, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy? ↗
October 03, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? ↗
October 01, 2026
Via The Motley Fool
Topics Economy
News headline image
Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale ↗
October 01, 2026
Via The Motley Fool
News headline image
Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement
October 01, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb’s CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) in Adults and Pediatric Patients*
September 30, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
Q2 Earnings Outperformers: Jazz Pharmaceuticals (NASDAQ:JAZZ) And The Rest Of The Pharmaceuticals Stocks
September 29, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Bristol Myers Squibb vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 29, 2026
Via The Motley Fool
News headline image
Here Are My Top 2 High-Yield Healthcare Stocks to Buy Now ↗
September 29, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Numbers That Explain Bristol Myers Squibb's Dirt Cheap Valuation ↗
September 29, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
1 Cash-Producing Stock to Keep an Eye On and 2 Facing Challenges
September 29, 2026
Via StockStory
News headline image
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 27, 2026
Via The Motley Fool
News headline image
Kevin Warsh Just Signaled Higher-for-Longer Rates. Here's What That Means for Big Pharma Dividend Stocks. ↗
September 27, 2026
Via The Motley Fool
Topics Bonds Economy
News headline image
Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma
September 25, 2026
From Bristol Myers Squibb
Via Business Wire

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 59.12
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 10/09/26 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 131.37B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 131B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap